Breaking News Instant updates and real-time market news.

INTC

Intel

$35.04

-0.39 (-1.10%)

, BABA

Alibaba

$105.09

-2.16 (-2.01%)

04:55
03/22/17
03/22
04:55
03/22/17
04:55

ShopTalk to hold a conference

ShopTalk 2017 is being held in Las Vegas on March 19-22.

INTC

Intel

$35.04

-0.39 (-1.10%)

BABA

Alibaba

$105.09

-2.16 (-2.01%)

CRM

Salesforce

$81.55

-1.35 (-1.63%)

AMZN

Amazon.com

$843.20

-13.77 (-1.61%)

UN

Unilever; also tag UL

$49.89

-0.23 (-0.46%)

UL

Unilever; also tag UN

$50.04

-0.16 (-0.32%)

RAD

Rite Aid

$4.48

-0.23 (-4.88%)

ADBE

Adobe

$125.07

-1.24 (-0.98%)

WMT

Wal-Mart

$69.90

-0.08 (-0.11%)

MAT

Mattel

$24.96

-0.35 (-1.38%)

LOW

Lowe's

$81.92

-0.43 (-0.52%)

PBI

Pitney Bowes

$12.61

-0.17 (-1.33%)

EBAY

eBay

$33.19

-0.62 (-1.83%)

GGP

GGP

$23.21

0.02 (0.09%)

COWN

Cowen Group

$12.65

-0.55 (-4.17%)

HSNI

HSN, Inc.

$35.85

-0.35 (-0.97%)

TGT

Target

$53.39

-0.98 (-1.80%)

SPLS

Staples

$8.64

-0.19 (-2.15%)

WSM

Williams-Sonoma

$47.86

-0.64 (-1.32%)

P

Pandora

$11.51

-0.21 (-1.79%)

UPS

UPS

$106.51

-0.61 (-0.57%)

V

Visa

$88.06

-1.12 (-1.26%)

TWTR

Twitter

$14.54

-0.55 (-3.64%)

BBY

Best Buy

$44.06

-1.49 (-3.27%)

GOOG

Alphabet

$830.46

-17.94 (-2.11%)

FB

Facebook

$138.51

-1.43 (-1.02%)

PJC

Piper Jaffray

$63.35

-3.9 (-5.80%)

IBM

IBM

$173.88

-1.82 (-1.04%)

ANF

Abercrombie & Fitch

$11.43

-0.24 (-2.06%)

SSNLF

Samsung

KSS

Kohl's

$37.64

-0.92 (-2.39%)

UA

Under Armour

$17.52

-0.74 (-4.05%)

PEP

PepsiCo

$111.77

0.62 (0.56%)

GPS

Gap

$22.82

-0.64 (-2.73%)

AXP

American Express

$77.53

-1.32 (-1.67%)

  • 22

    Mar

  • 23

    Mar

  • 27

    Mar

  • 27

    Mar

  • 28

    Mar

  • 28

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    Mar

  • 04

    Apr

  • 05

    Apr

  • 05

    Apr

  • 18

    Apr

  • 02

    May

  • 16

    May

  • 21

    May

  • 22

    May

  • 02

    Jun

  • 08

    Jun

  • 20

    Jun

  • 22

    Jun

INTC Intel
$35.04

-0.39 (-1.10%)

03/15/17
FBCO
03/15/17
DOWNGRADE
Target $35
FBCO
Neutral
Intel downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst John Pitzer downgraded Intel to Neutral and lowered his price target for the shares to $35 from $45. Intel is a better company than a stock, Pitzer tells investors in a research note.
03/20/17
PIPR
03/20/17
DOWNGRADE
Target $63.54
PIPR
Neutral
Mobileye downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Alexander Potter downgraded Mobileye (MBLY) to Neutral saying that while demanding a higher buyout price may be justified, he "begrudgingly" concluded that the price Intel (INTC) is paying for the company is fair. The analyst raised his price target for Mobileye shares to $63.54 from $60 to reflect Intel's offer.
03/20/17
03/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Pivotal Research analyst Brian Wieser downgraded Alphabet (GOOGL) to Hold from Buy citing brand safety concerns and valuation following the recent rally in the shares. News last week that Havas, the sixth largest global media network, is pulling its spending from Google's YouTube and Google Display Network in the U.K. because Google was "unable to provide specific reassurances, policy and guarantees that their video or display content is classified either quickly enough or with the correct filters" is a big deal, Wieser tells investors. 2. Canaccord analyst Lynne Collier downgraded Sonic (SONC) to Hold from Buy, citing challenging industry sales, the potential for Street estimates to be too high in the midst of soft sales, a lack of upcoming catalysts, and increasing competition from non-traditional venues such as convenience stores. 3. Piper Jaffray analyst Alexander Potter downgraded Mobileye (MBLY) to Neutral saying that while demanding a higher buyout price may be justified, he "begrudgingly" concluded that the price Intel (INTC) is paying for the company is fair. The analyst raised his price target for Mobileye shares to $63.54 from $60 to reflect Intel's offer. 4. Susquehanna analyst Sam Poser downgraded Caleres (CAL) citing the company's "disappointing" results and his belief that the company will not be able to overcome industry headwinds. 5. Goldman Sachs analyst Conor Fitzgerald downgraded Stifel Financial (SF) to Neutral from Buy while raising his price target for the shares to $59 from $58. The analyst believes LPL Financial (LPLA), a stock he upgraded this morning to Conviction Buy, offers more upside at current valuations. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/17
JEFF
03/20/17
NO CHANGE
Target $16
JEFF
Buy
Jefferies sees more share gains for AMD, ups target to $16
Jefferies analyst Mark Lipacis raised his price target for AMD (AMD) to $16 from $13 citing better visibility into the Ryzen 7 high-performance and Ryzen 5 power-performance desktop processor launch. The chipmaker closed Friday down 16c to $13.49. As AMD continues to roll out its Ryzen product offerings, incremental share gains will continue to expand in the near term, Lipacis tells investors in a research note. He believes the company's "ability to price between-the-seams" while achieving competitive performance will result in "meaningful" share gains from Intel (INTC) in the Desktop, Server, and Notebook markets starting in 2017. The analyst upped his estimates for AMD and keeps a Buy rating on the shares.
BABA Alibaba
$105.09

-2.16 (-2.01%)

03/14/17
BTIG
03/14/17
NO CHANGE
BTIG
BTIG says Western Union positive reaction to MoneyGram news makes sense
BTIG analyst Mark Palmer said he believes the uptick in Western Union (WU) shares after the announcement of Euronet's (EEFT) offer to buy competitor MoneyGram (MGI) makes some sense as Euronet may be seen as less of a competitive threat than Alibaba's (BABA) Ant Financial, which previously struck a deal to buy MoneyGram, and the bid underscores the attractiveness and potential of the global remittance space. However, speculation that if Ant was unsuccessful in its effort to acquire MoneyGram it could look to acquire VeriFone (PAY) or Green Dot (GDOT) "makes less sense," said Palmer.
03/14/17
RHCO
03/14/17
NO CHANGE
RHCO
Buy
SunTrust says buy Euronet on MoneyGram deal selloff
Euronet's (EEFT) $1.8B offer to acquire MoneyGram (MGI) is "superior in all ways" to Ant Financial's, which is owned by Alibaba (BABA), SunTrust analyst Andrew Jeffrey tells investors in a research note. He expects shares of Euronet to come under pressure this morning "as many investors simply do not like global remittance." Jeffrey recommends using the weakness to buy Euronet, however, as he feels the company has a differentiated franchise and superior management and growth strategy.
01/26/17
BARD
01/26/17
NO CHANGE
Target $116
BARD
Outperform
MoneyGram deal consistent with Ant Financial expansion strategy, says Baird
Baird analyst Colin Sebastian views Alibaba (BABA) affiliate Ant Financial's deal to acquire MoneyGram (MGI) as consistent with Ant's recent efforts to expand its global payments network. The deal may help Ant expand usage of the AliPay digital wallet in the U.S., while driving additional MoneyGram transaction volume in the Asia-Pacific region, though there is significant competition in online money transfer from incumbents such as PayPal's (PYPL) Xoom, Sebastian added. He keeps an Outperform rating and $116 price target Alibaba.
03/08/17
COWN
03/08/17
NO CHANGE
Target $35
COWN
Underperform
TripAdvisor Chairman comments bad sign for fundamentals, says Cowen
Cowen analyst Kevin Kopelman says comments Monday night from TripAdvisor (TRIP) Chairman Greg Maffei regarding takeover potential is a bad sign for fundamentals. Maffei noted that another owner of the TripAdvisor business could see more value in its 375M unique travel users a month and that Alibaba (BABA), Facebook (FB) and Amazon.com (AMZN) may be acquirers in the space, Kopelman tells investors in a research note. The analyst interpreted Maffei's comments as "acknowledging a lack of fundamental top line or profit metrics" from TripAdvisor in the near-term. He believes, however, that the comments will increase takeout speculation in the name. Kopelman keeps an Underperform rating on TripAdvisor with a $35 price target.
CRM Salesforce
$81.55

-1.35 (-1.63%)

03/07/17
PIPR
03/07/17
NO CHANGE
Target $100
PIPR
Overweight
IBM deal achieves Salesforce Service Cloud deployment goal, says Piper Jaffray
Piper Jaffray analyst Alex Zukin said the artificial intelligence deal announced last night with IBM (IBM) is important for Salesforce (CRM) as it achieves the company goal of getting a traditional large competitor to deploy Service Cloud and because it could lead to other future strategic transactions. The analyst also noted Salesforce CEO Marc Benioff used the occasion to offer an "interesting...bit of color" that he doesn't see any acquisitions in the short-term, while pointing out that M&A and slowing growth were recurring investor concerns last year. Zukin, who continues to see Salesforce having the ability to get to $20B in revenue, keeps an Overweight rating and $100 price target on the stock.
03/07/17
STFL
03/07/17
NO CHANGE
STFL
Salesforce deal positive, says Stifel
After Salesforce (CRM) and IBM (IBM) announced the formation of a global strategic partnership around artificial intelligence, Stifel analyst Tom Roderick says that the deal indicates that Salesforce is making positive progress in the space. The analyst keeps a Buy rating on Salesforce.
03/01/17
03/01/17
NO CHANGE

Salesforce should be bought on any weakness, says Pacific Crest
Pacific Crest analyst Brent Bracelin notes that the number of Salesforce's $20M plus deals more than doubled last year, while its billings growth accelerated to 33% last quarter. The analyst keeps a $95 price target and an Overweight rating on the stock. He recommends buying the shares on any weakness.
03/01/17
RBCM
03/01/17
NO CHANGE
RBCM
Salesforce should be bought on weakness, says RBC Capital
After Salesforce reported higher than expected Q4 billings but its Q1 billings guidance came in below expectations, RBC Capital analyst Ross MacMillan blames the miss on Q4 deferred revenue strength, one extra revenue day in Q1, and foreign exchange issues. He says that the company's growth and execution "is unrivaled in software." The analyst recommends buying the shares on weakness.
AMZN Amazon.com
$843.20

-13.77 (-1.61%)

03/17/17
03/17/17
NO CHANGE

Feedback on Microsoft cloud more positive, says Pacific Crest
Microsoft's (MSFT) cloud partners have become more upbeat on the company's cloud business, Azure, according to Pacific Crest analyst Brent Bracelin. The analyst says that Azure has "become a viable alternative to" Amazon's (AMZN) AWS. He continues to recommend buying Microsoft stock. .
03/17/17
03/17/17
NO CHANGE

Growth of Amazon.com cloud business could moderate, says Pacific Crest
Pacific Crest analyst Brent Bracelin says that heavy investments by Microsoft (MSFT) and Google (GOOG, GOOGL) could make their cloud businesses more competitive with Amazon's (AMZN) AWS. The analyst says that AWS' growth could decelerate this year and in 2018. He lowered his estimates for Amazon and cut his price target on the name to $895 from $905 but keeps an Overweight rating on the shares.
03/09/17
03/09/17
NO CHANGE

Macquarie has ten concerns about lululemon
Macquarie analyst Laurent Vasilescu outlined his ten concerns about lululemon (LULU). Specifically, he says that the company's store comps are in the low single percentage digits, the company continues to reduce the amount of information it discloses about its gross margins, its men's and ivivva projects are margin dilutive, the U.S. market has reached saturation, its U.S. stores are margin dilutive, it's not investing enough in marketing, it invests almost nothing in R&D and is not a tech company as it claims, it's facing new competition from Amazon (AMZN), Beyonce and denim, and it has high fixed SG&A costs and inventories. The analyst adds that the stock historically does well after the Q4 results and then retreats. He keeps a $44 price target and an Underperform rating on the name.
03/10/17
RBCM
03/10/17
NO CHANGE
RBCM
Amazon may see major boost from voice-activated Internet, says RBC Capital
RBC Capital analyst Mark Mahaney estimates that voice-activated Internet could generate $10B in revenue for Amazon (AMZN) by 2020. The analyst adds that voice-activated Internet "represents a material opportunity" for Alphabet (GOOG, GOOGL). Mahaney keeps a $900 price target and an Outperform rating on Amazon.
UN Unilever; also tag UL
$49.89

-0.23 (-0.46%)

02/27/17
BOFA
02/27/17
UPGRADE
BOFA
Neutral
Unilever upgraded to Neutral from Underperform at BofA/Merrill
BofA/Merrill analyst David Hayes upgraded Unilever to Neutral and increased the target price to $45 from $35 due to valuation and believes the strategic review could accelerate margin development targets over the next 4 years.
02/23/17
SOCG
02/23/17
UPGRADE
SOCG
Buy
Unilever upgraded to Buy from Hold at Societe Generale
Societe Generale analyst Warren Ackerman upgraded Unilever to Buy and raised his price target for the shares to EUR 50 from EUR 42.
02/27/17
02/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) upgraded to Buy from Neutral at B. Riley by analyst Jeff Van Sinderen, who said last week's footwear show and latest channel checks underscore the company's potential for growth. 2. Illumina (ILMN) upgraded to Buy from Hold at Evercore ISI by analyst Ross Muken following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. 3. Carnival (CCL) upgraded Buy from Hold by Argus analyst John Staszak, who now believes that "continued " improvement in demand for cruises will improve the company's earnings and margins. 4. Cempra (CEMP) upgraded to Buy at Roth Capital by analyst Michael Higgins after the company announced positive Phase 3 results in the first of two skin infection studies with Taksta, and ahead of bone data in 2017. The analyst also raised his price target on the shares to $8 from $2.50. 5. Unilever (UN) upgraded to Neutral from Underperform at BofA Merrill Lynch by analyst David Hayes, citing valuation and his belief that the strategic review could accelerate margin development targets over the next 4 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/03/17
SBSH
03/03/17
NO CHANGE
SBSH
Kraft may look at General Mills, Kellogg, says Citi
In the wake of Kraft Heinz's (KHC) bid for Unilever (UN), Citi analyst Adam Spielman weighed in on the implications for consumer staples globally and said he thinks further M&A is likely, most probably in the U.S. He believes Kraft may still look at Unilever's food assets, or could target General Mills (GIS) or Kellogg (K). He also sees Mondelez (MDLZ) as a possible, but less likely, target for Kraft. Unilever could react by entering new categories, but Spielman sees it as more likely to reinforce existing strengths, "which points to" Colgate (CL) or Edgewell (EPC), he tells investors.
UL Unilever; also tag UN
$50.04

-0.16 (-0.32%)

RAD Rite Aid
$4.48

-0.23 (-4.88%)

01/30/17
LEER
01/30/17
NO CHANGE
LEER
Outperform
Walgreens Boots Alliance, Rite Aid transaction still in-process, says Leerink
Leerink analyst David Larsen notes that he has confirmed with Walgreens Boots Alliance (WBA) that the deal with Rite Aid (RAD) would only terminate if either party were to walk away, which would require a formal announcement. Therefore, the analyst believes "no news is good news," and that the transaction is still in-process and on track. He reiterates an Outperform rating on Walgreens Boots Alliance's shares.
01/20/17
EVER
01/20/17
NO CHANGE
EVER
Rite Aid could trade to $3.50 or below if deal is not completed, says Evercore ISI
Evercore ISI analyst Ross Muken believes Rite Aid (RAD) could have "massive" downside and would likely trade to $3.50 or below if the acquisition by Walgreens Boots Alliance (WBA) were not completed. For Walgreens, Muken said, if the deal is not completed, it would be a modest negative given the synergy potential and time committed to deal closure, but he expects Walgreen not to sit on the capital for very long and would look for a combination of share repurchases and additional M&A in the not-too-distant future.
03/21/17
DBAB
03/21/17
NO CHANGE
DBAB
Deutsche says Rite Aid could fall 53% if Walgreens deal fails
Deutsche Bank analyst George Hill points out that according to recent media reports, the Federal Trade Commission still has issues with Walgreens Boots Alliance's (WBA) proposed acquisition of Rite Aid (RAD) as well as Fred's (FRED) as a buyer of divested stores. Should the deal fail to close, Walgreens shares have downside to the $73-$79 range, or up to 14%, Hill tells investors in a research note, citing his analysis. Rite Aid shares, the analyst suspects, could fall to $2.25 per share, or 53% from current levels, the analyst contends. He believes a key to Walgreens' decision to certify compliance with the second request could be the current makeup of the FTC, which has three vacant seats along with a Democratic Commissioner and Republican Chairperson. Hill has a Buy rating on Walgreens with a $92 price target, which he notes excludes Rite Aid.
01/20/17
01/20/17
NO CHANGE

Rite Aid-Walgreens deal closing 'way more likely than not,' says Cowen
After a Bloomberg article said that the FTC is concerned about the sale of Rite Aid (RAD) stores to Fred's (FRED) as a remedy to concerns about Walgreens' (WBA) takeover deal, Cowen analyst Charles Rhyee said that the report could reflect a split staff at FTC and the losing side making some noise or it could be a public negotiating tactic. Given the various paths forward, including litigation, Rhyee still thinks it is "way more likely than not" that this deal will ultimately close and views the weakness in Walgreens shares as a buying opportunity.
ADBE Adobe
$125.07

-1.24 (-0.98%)

03/17/17
03/17/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Adobe (ADBE) upgraded to Buy from Hold at Wunderlich with analyst Ryan Macdonald citing the company's better than expected first quarter results. The analyst raised his price target for the shares to $145 from $115. 2. L Brands (LB) upgraded to Outperform from Market Perform at FBR Capital with analyst Susan Anderson saying her survey work shows that Victoria Secret has not lost share over the past year and that same-store-sales will be better than expected in the second half of 2017. 3. Vertex (VRTX) upgraded to Outperform from Market Perform at JMP Securities with analyst Liisa Bayko saying the company's triple combo data this year could expand its cystic fibrosis patient pool by greater than 50%. Positive triple combo data could make Vertex a takeover target, Bayko adds. 4. Dean Foods (DF) upgraded to Overweight from Neutral at JPMorgan with analyst Ken Goldman raising his estimates to reflect lower raw dairy costs. The outlook for Dean's largest input, Class I milk, has softened in recent months, Goldman tells investors in a research note. The analyst raised his price target for the shares to $22 from $20. 5. Barclays (BCS) upgraded to Overweight from Equal Weight at Morgan Stanley. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/17/17
JMPS
03/17/17
NO CHANGE
JMPS
Adobe price target raised to $138 from $120 at JMP Securities
JMP Securities analyst Patrick Walravens raised his price target on Adobe as he believes that the company reported "strong" Q1 results. The analyst expects the company "to continue to drive profitable growth." He keeps an Outperform rating on the shares.
03/17/17
BOFA
03/17/17
NO CHANGE
Target $160
BOFA
Buy
Adobe price target raised to $160 from $125 at BofA/Merrill
BofA Merrill Lynch analyst Kash Rangan called Adobe management conservative in maintaining their FY17 guidance after the company's strong "beat and raise" Q1 report, adding that he was surprised that net new Creative Cloud ARR and digital media ARR doubled year-over-year in the quarter. The analyst, who said the results give him more confidence in his long-term bull case, reiterates a Buy rating and raised his price target on Adobe to $160 from $125.
03/17/17
ADAM
03/17/17
NO CHANGE
Target $145
ADAM
Buy
Adobe price target raised to $145 from $125 at Canaccord
Canaccord analyst Richard Davis raised his price target on Adobe to $145 from $125 following Q1 results. The analyst believes the company has the right formula to organically expand its addressable market and cited its beat on all metrics with guidance suggesting continued strength into Q2. Davis said Adobe is the highest quality large-cap software name and reiterated his Buy rating on the shares.
WMT Wal-Mart
$69.90

-0.08 (-0.11%)

03/14/17
BOFA
03/14/17
NO CHANGE
Target $88
BOFA
Buy
Wal-Mart added US 1 List at BofA/Merrill
BofA/Merrill analyst Robert Ohmes added Wal-Mart to his firm's US 1 List saying the retailer's core U.S. strategy should continue to work in its current fiscal year. He expects the stock's valuation multiple to expand as its success in e-commerce continues. The analyst keeps a Buy rating on Wal-Mart with an $88 price target.
02/13/17
PIPR
02/13/17
NO CHANGE
Target $83
PIPR
Overweight
Target risk/reward compelling ahead of investor day, says Piper Jaffray
Piper Jaffray analyst Sean Naughton says Target's (TGT) risk/reward is "compelling" ahead of the company's investor day. The stock, trading at a 21% discount to most direct peer Wal-Mart (WMT), is pricing in much of the near-term downside, Naughton tells investors in a research note. Target is "under-loved" and remains a "great brand with good assets and strong free cash flow," the analyst contends. He keeps an Overweight rating on the shares with an $83 price target.
02/22/17
BOFA
02/22/17
UPGRADE
Target $88
BOFA
Buy
Wal-Mart upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Robert Ohmes upgraded Wal-Mart to Buy and raised its price target to $88 from $76 saying the US strategy is working and risk/reward is favorable on e-com sales momentum. The analyst said Q4 US e-com GMV growth was up 36% year-over-year and believes the company is entering a period of 20-30%+ e-com growth and expects the multiple to rise as e-com success increases and recent acquisitions go into the US comp.
02/22/17
02/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Wal-Mart (WMT) upgraded to Buy from Neutral at BofA/Merrill with analyst Robert Ohmes saying the U.S. strategy is working and risk/reward is favorable on e-commerce sales momentum. 2. Scorpio Tankers (STNG) upgraded to Buy from Hold at ABN Amro with analyst Glenn Lodden raising his price target for the shares to $7.50 from $4.30. 3. Parker-Hannifin (PH) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying her analysis suggests the company's synergy targets for the Clarcor (CLC) acquisition are "overly conservative." The analyst feels the deal "makes good strategic sense." She raised her price target for Parker-Hannifin shares to $173 from $146. 4. STMicroelectronics (STM) upgraded to Overweight from Equal Weight at Barclays with analyst Andrew Gardiner saying further market share and content gains will show during 2017. 5. Ecolab (ECL) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
MAT Mattel
$24.96

-0.35 (-1.38%)

03/14/17
UBSW
03/14/17
NO CHANGE
UBSW
Buy
UBS discusses scenarios for hypothetical Mattel/Hasbro merger
UBS analyst Arpine Kocharyan noted market speculation about a potential merger of Hasbro (HAS) and Mattel (MAT). While admitting she has no view on the possibility of a deal happening, she does say there is large equity valuation gap between the two, with Mattel pricing in a potential dividend cut, and expressed her view that industry consolidation could pick up in 2017. Koocharyan maintains her Buy rating on Mattel and Neutral rating on Hasbro shares.
02/08/17
PIPR
02/08/17
NO CHANGE
PIPR
Piper discusses resurfacing of Hasbro, Mattel deal speculation
Piper Jaffray analyst Stephanie Wissink points out that over her firm's 15 years of coverage, speculation of a merger between Hasbro (HAS) and Mattel (MAT) has surfaced several times. Hasbro's strong Q4 earnings report and share rally, in contrast with Mattel's negative Q4 preannouncement and pullback, has reignited the conjecture, Wissink tells investors in a research note. Economically a merger would create value, but a combination of the number two and three toy companies "would require significant evaluation from anti-trust authorities," the analyst writes. She believes a deal is possible if the Federal Trade Commission widens the boundaries around "youth entertainment & play," say to include video games, digital games and media. Hasbro closed yesterday up 67c to $94.98 while Mattel, after rallying in early trading, closed down 4c to $25.88. Wissink adds that she can find upwards of $500M of merger synergies if the two companies were to combine.
02/13/17
GSCO
02/13/17
INITIATION
Target $27
GSCO
Neutral
Mattel initiated with a Neutral at Goldman
Goldman analyst Michael Ng initiated Mattel with a Neutral and a $27 price target. The analyst said Mattel is undergoing a turnaround in several of its core brands but consensus estimates are already looking for a meaningful recovery, creating increased risk.
02/13/17
02/13/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Air Products (APD) reinstated with an Overweight at Barclays. 2. Hasbro (HAS) was initiated with a Buy at Goldman, while Mattel (MAT) was initiated with a Neutral. 3. Jagged Peak Energy (JAG) initiated with a Positive at Susquehanna. 4. Kimbell Royalty Partners (KRP) initiated with a Buy at Wunderlich. 5. HollyFrontier (HFC) reinstated with a Sell at Goldman. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
LOW Lowe's
$81.92

-0.43 (-0.52%)

03/02/17
UBSW
03/02/17
NO CHANGE
Target $91
UBSW
Buy
Lowe's has favorable setup for coming year, says UBS
UBS analyst Michael Lasser said Lowe's (LOW) has a favorable setup for the coming year. He cited the company's growth in higher comp items versus Home Depot (HD) in six of the past 10 quarters. Lasser said the growth, coupled with continued momentum in its Pro business, improved execution, and a favorable macro backdrop, sets the company up well. Lasser reiterated his Buy rating and raised his price target to $91 from $85 on Lowe's shares.
02/07/17
BERN
02/07/17
INITIATION
BERN
Underperform
Lowe's initiated with an Underperform at Bernstein
Bernstein analyst Brandon Fletcher says that Lowe's comparable store sales may decelerate if the housing markets in the U.S. and Canada moderate. Fletcher thinks that the company's spending reduction targets are "overly optimistic." Target $66.
02/07/17
02/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Target (TGT) and Dollar General (DG) were initiated with an Outperform at Bernstein, while Lowe's (LOW) was initiated with an Underperform. The firm also initiated Costco (COST), Home Depot (HD), and Wal-Mart (WMT) with a Market Perform. 2. Aetna (AET) and UnitedHealth (UNH) were assumed with an Overweight at Cantor. 3. Philips (PHG) initiated with a Hold at Berenberg. 4. Costamare (CMRE) initiated with a Neutral at Citi. 5. BioMarin (BMRN) initiated with an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
02/23/17
02/23/17
UPGRADE
Target $165

Overweight
Morgan Stanley says not too late to play housing recovery, upgrades Home Depot
As previously reported, Morgan Stanley analyst Simeon Gutman upgraded Home Depot (HD) to Overweight from Equal Weight, stating that he now has a more robust view of home improvement industry growth after the firm's deep dive analysis suggested the housing recovery is in the "middle innings," not the "8th/9th" inning as the consensus suggests. Additionally, rising rates may take even longer to impact home improvement spending in this cycle, Gutman contends. In addition to the rating change, he raised his price target on Home Depot shares to $165 from $150 and also hiked his target on peer Lowe's (LOW) to $88 from $83 while reiterating an Overweight rating on its shares.
PBI Pitney Bowes
$12.61

-0.17 (-1.33%)

11/02/16
BMUR
11/02/16
NO CHANGE
Target $20
BMUR
Buy
Pitney Bowes structural changes impacted business, says Brean Capital
Brean Capital analyst Ananda Baruah said structural changes at Pitney Bowes impacted the timing of payments for its Finance business, causing a miss of quarterly estimates. The analyst said the company believes they will exit the December quarter having resolved the Financing issue and earnings will become more stabilized. Baruah maintained his Buy rating but lowered his price target to $20 from $24 on Pitney Bowes shares.
EBAY eBay
$33.19

-0.62 (-1.83%)

01/26/17
PIPR
01/26/17
NO CHANGE
Target $30
PIPR
Neutral
Piper not convinced after eBay's 'mixed' quarter
Piper Jaffray analyst Michael Olson views eBay's Q4 results as "mixed," with most key metrics at or slightly below expectations. The "relatively solid" quarter coupled with negative sentiment on the stock drove the post-earnings share rally, Olson tells investors in a research note. While he raised his price target for the shares to $30 from $28, the analyst is not convinced that structured data and increased marketing can fix eBay's structural brand and product issues. Olson keeps a Neutral rating on the name.
02/17/17
KEYB
02/17/17
INITIATION
KEYB
Sector Weight
eBay coverage resumed with a Sector Weight at KeyBanc
KeyBanc says that the benefits from eBay's recent emphasis on "structured data" and AI are "limited" and already reflected in the stock. The firm adds that its checks on the company are "mixed," and it thinks that the shares are worth around $35.
01/03/17
AGIS
01/03/17
INITIATION
Target $36
AGIS
Buy
eBay initiated with a Buy at Aegis
Aegis analyst Victor Anthony initiated eBay with a Buy and a a $36 price target. Anthony said the core marketplace is stabilizing, StubHub is executing, the Classifieds businesses is continuing to grow at a double-digit pace, and management is returning capital through aggressive share repurchases. The analyst believes approximately $5B-$7.5B, or $4-$7 per-share, of value could be potentially unlocked with StubHub and Classifieds and views valuation as un-demanding.
01/26/17
SBSH
01/26/17
NO CHANGE
Target $36
SBSH
Buy
eBay quarter 'better than feared,' says Citi
Citi analyst Mark May says eBay's Q4 results and outlook were "better than feared." Despite mixed datapoints and sentiment into the results, eBay posted GMV growth that was slightly better than expected and provided a better than forecasted outlook for 2017, May tells investors in a research note. He upped his price target for the shares to $36 from $34 and keeps a Buy rating on the name.
GGP GGP
$23.21

0.02 (0.09%)

03/14/17
UBSW
03/14/17
DOWNGRADE
Target $25
UBSW
Neutral
GGP downgraded to Neutral from Buy at UBS
UBS analyst Jeremy Metz downgraded GGP to Neutral after lowering his sector view on Malls to Marketweight from Overweight. The analyst does not see headwinds in the sector easing in the short term and cut his price target for GGP shares to $25 from $28.
01/09/17
DBAB
01/09/17
DOWNGRADE
Target $27
DBAB
Hold
General Growth downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Vin Chao downgraded General Growth Properties to Hold saying 2017 will be a transition year for the REIT space as rising rates pushes cap rates higher. The analyst lowered his price target for the shares to $27 from $36.
10/14/16
SDLR
10/14/16
UPGRADE
SDLR
Buy
General Growth upgraded to Buy from Hold at Sandler O'Neill
03/14/17
03/14/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Corning (GLW) downgraded to Neutral from Buy at Goldman with analyst Doug Clark citing valuation with the stock up 33% since his upgrade back in April of 2016. The analyst keeps a $29 price target for the shares. 2. Amphastar (AMPH) downgraded to Outperform from Strong Buy at Raymond James with analyst Elliot Wilbur saying he sees an increased near-term risk profile following indications from FDA that Amphastar may have to withdraw its epinephrine product. 3. Abbott (ABT) downgraded to Market Perform from Outperform at BMO Capital. 4. GGP (GGP) downgraded to Neutral from Buy at UBS with analyst Jeremy Metz saying he does not see headwinds in the sector easing in the short term and cut his price target for GGP shares to $25 from $28. 5. Harmonic (HLIT) downgraded to Hold from Buy at Drexel Hamilton. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COWN Cowen Group
$12.65

-0.55 (-4.17%)

07/29/16
JMPS
07/29/16
NO CHANGE
JMPS
Cowen core business trends better than headline results, says JMP Securities
JMP Securities analyst Devin Ryan believes that Cowen's Q2 fundamentals were better than its results indicated. Ryan says that the company's core revenues were "generally solid," and he thinks that the company is executing well vis-a-vis its core business. The analyst says that Cowen was "constructive" about its investment banking backlog, and he keeps a $5 price target and Outperform rating on the shares.
HSNI HSN, Inc.
$35.85

-0.35 (-0.97%)

11/08/16
MAXM
11/08/16
NO CHANGE
Target $54
MAXM
Buy
HSN, Inc. price target lowered to $54 from $61 at Maxim
Maxim analyst Tom Forte noted HSN, Inc. (HSNI) reported Q3 sales and EPS that missed estimates, which he said was partly due to some divestitures. Following the report, he decreased his 2016 and 2017 sales projections and lowered his price target on HSN shares to $54 from $61, but maintains his Buy rating, contending that HSN will see improving operating results as it benefits from easier comparisons. Forte also sees the potential for a potential merger of HSN with QVC (QVCA) as being higher than it was entering the year given the recent pressure on both of their shares.
11/08/16
UBSW
11/08/16
NO CHANGE
Target $50
UBSW
Buy
HSN, Inc. price target lowered to $50 from $60 at UBS
UBS analyst Eric Sheridan lowered his price target on HSN, Inc. to $50 from $60 following Q3 results. The analyst said the quarter was disappointing with both revenues and continued gross margin pressure. Sheridan believes 2017 will be better for the company's operations and returns and with the stock approaching low historical multiples, he maintained his Buy rating on HSN, Inc. shares.
11/29/16
MAXM
11/29/16
NO CHANGE
Target $54
MAXM
Buy
Maxim encouraged by HSN, Inc. selection of Little as CFO
Maxim analyst Tom Forte noted Rod Little has an extensive background in beauty and consumer packaged goods given his time at Elizabeth Arden (RDEN) and Procter & Gamble (PG) and said he is "encouraged" by his selection as CFO of HSN Inc. (HSNI). Forte, who thinks Little can help HSN as it tries to reignite sales growth, keeps a Buy rating and $54 price target on the shares.
02/23/17
CHLM
02/23/17
NO CHANGE
Target $45
CHLM
Hold
HSN, Inc. price target raised to $45 from $35 at Craig-Hallum
Craig-Hallum analyst Alex Fuhrman raised his price target for HSN, Inc. to $45 from $35 following Q4 results and as he believes the company is on the verge of returning to growth in 2017. The analyst reiterates a Hold rating on the shares.
TGT Target
$53.39

-0.98 (-1.80%)

03/01/17
BERN
03/01/17
NO CHANGE
BERN
Dollar General unlikely to be affected by Target price cuts, says Bernstein
Bernstein analyst Brandon Fletcher says that Dollar General's (DG) stock fell due to worries about Target's (TGT) price cuts. however, Fletcher does not believe that there is significant overlap between the two companies' customer base or between their geographic markets, so he does not expect Dollar General to be signficantly affected by Targets moves. The analyst keeps a $91 price target and an Outperform rating on Dollar General.
03/01/17
GSCO
03/01/17
NO CHANGE
Target $53
GSCO
Sell
Target price target lowered to $53 from $67 at Goldman
Goldman analyst Matthew Fassler maintained his Sell rating on Target (TGT) saying its categories, markets, and customers are likely to move to more online options, including Amazon.com (AMZN), and it will be difficult for Target to establish price or assortment edge on commoditized goods. He questions if a direct distribution model focused around stores optimizes costs versus peers and how it will weather a move toward Everyday low prices and away from promotions. Fassler lowered his price target to $53 from $67 and said he expects earnings erosion to continue beyond the first year of investment.
03/01/17
WOLF
03/01/17
DOWNGRADE
WOLF
Underperform
Target downgraded to Underperform from Peer Perform at Wolfe Research
03/01/17
LEHM
03/01/17
NO CHANGE
Target $50
LEHM
Underweight
Target price target lowered to $50 from $60 at Barclays
Barclays analyst Matthew McClintock lowered his price target for Target to $50 saying the valuation should trade at a discount to historical levels. The company's plan only calls for stabilization in the business starting in 2019, with 2017 being an investment phase and 2018 being a transition phase, McClintock tells investors in a post-earnings research note. The analyst keeps an Underweight rating on shares of Target.
SPLS Staples
$8.64

-0.19 (-2.15%)

12/13/16
LOOP
12/13/16
INITIATION
Target $10
LOOP
Hold
Staples initiated with a Hold at Loop Capital
Loop Capital analyst Anthony Chukumba initiated Staples with a Hold and a $10 price target.
05/23/16
BOFA
05/23/16
UPGRADE
BOFA
Buy
Staples upgraded to Buy from Underperform at BofA/Merrill
BofA/Merrill analyst Denise Chai upgraded Staples (SPLS) two notches to Buy from Underperform and raised her price target to $10 from $8.50. The analyst said the sell-off following the termination of the Office Depot (ODP) merger has created an attractive entry point ahead of a potential earnings upside as Staples focuses on core strengths in Beyond Office Supplies and mid-market while downsizing its retail footprint and potentially divesting loss-making European operations.
05/23/16
05/23/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Allegheny Technologies (ATI) double upgraded to Buy at BofA/Merrill by analyst Timna Tanners, who has increased confidence in the company's engine positioning giving a solid outlook for aerospace and a more neutral view on nickel prices. 2. Universal Display (OLED) upgraded to Buy at Goldman with analyst Brian Lee saying the company should be a key beneficiary of Apple's (AAPL) first-time adoption of OLED displays for iPhone starting in 2017. 3. Schlumberger (SLB) upgraded to Conviction Buy at Goldman by analyst Waqar Syed, who said the company is best positioned for the "New Oil Order" due to its exposure to incremental sources of oil supply. 4. Square (SQ) upgraded to Buy at CLSA following the lockup expiration and overblown credit concerns. The firm said the lockup expiration is behind the company. 5. Staples (SPLS) double upgraded to Buy at BofA/Merrill by analyst Denise Chai, who said the sell-off following the termination of the Office Depot (ODP) merger has created an attractive entry point ahead of a potential earnings upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/09/17
BOFA
03/09/17
NO CHANGE
BOFA
Buy
Staples shares defended at BofA/Merrill
WSM Williams-Sonoma
$47.86

-0.64 (-1.32%)

03/13/17
FBCO
03/13/17
NO CHANGE
Target $44
FBCO
Neutral
Williams-Sonoma price target lowered to $44 from $50 at Credit Suisse
Credit Suisse analyst Seth Sigman lowered his price target for Williams-Sonoma to $44 from $50 ahead of Q4 results. Over the next year, the analyst believes that the combination of sluggish comps, incremental gross margin pressures from shipping and discounting, and higher investments will pressure EPS more than expected. He reiterates a Neutral rating on the shares.
03/16/17
WBLR
03/16/17
DOWNGRADE
WBLR
Market Perform
Williams-Sonoma downgraded to Market Perform from Outperform at William Blair
William Blair analyst Daniel Hofkin downgraded Williams-Sonoma to Market Perform following the company's Q4 results.
02/13/17
02/13/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Boeing (BA) downgraded to Underperform from Neutral at Buckingham with the firm saying at current levels, shares are priced for perfection and reflect optimistic free-cash-flow estimates. The firm's analyst expects Boeing shares to underperform on downward estimate revisions, a series of negative catalysts, and multiple compression. 2. Reynolds American (RAI) downgraded to Sector Perform from Outperform at RBC Capital. 3. Occidental Petroleum (OXY) downgraded to Neutral from Buy at Mizuho with analyst Timothy Rezvan citing valuation, muted dividend growth, and increasing unit expense trends. 4. AK Steel (AKS) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Kurtz saying he is concerned about AK's exposure to electrical steel and heavy auto steel, which could prove to be headwinds this year. 5. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Cristina Fernandez saying the company is fighting a more competitive environment and softer consumer spending by aggressively increasing promotions to maintain share. The analyst is surprised by the high level of promotions at West Elm and said some real estate contacts have noted softening store sales in December. Fernandez said the turnaround at Pottery Barn could take longer and sees limited margin expansion in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/16/17
03/16/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Biogen (BIIB) was downgraded to Equal Weight from Overweight at Morgan Stanley and Market Perform from Outperform at Leerink. 2. United Continental (UAL) downgraded to In Line from Outperform at Evercore ISI. 3. Tyson Foods (TSN) downgraded to Hold from Buy at Argus with analyst John Staszak citing the SEC probe of Tyson and other poultry producers, potential decelerating earnings in coming quarters, and a recent bird flu outbreak in two states. 4. Williams-Sonoma (WSM) downgraded to Market Perform from Outperform at William Blair with analyst Daniel Hofkin citing the company's fourth quarter results. 5. Inovio (INO) downgraded to Neutral from Overweight at Piper Jaffray with analyst Charles Duncan saying a "lack of focus and advancement for any one program" poses execution risk to the broader platform, and to shareholders. The analyst lowered his price target for the shares to $9 from $13 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
P Pandora
$11.51

-0.21 (-1.79%)

02/28/17
ADAM
02/28/17
NO CHANGE
Target $18
ADAM
Buy
Pandora Premium launch on track, says Canaccord
Canaccord analyst Michael Graham said Pandora's Premium launch appears to be on track for late March and he expects the initial conversion trends should be solid. The analyst said the ad load sampling shows continued high ad load and a resurgence in local advertising. He notes the most important metric over the next 6-12 months will be subscriber growth and he believes the company can deliver. Graham reiterated his Buy rating and $18 price target on Pandora shares.
01/30/17
MSCO
01/30/17
UPGRADE
MSCO
Media sector ugpraded to Attractive from Cautious at Morgan Stanley
Morgan Stanley analysts led by Benjamin Swinburne upgraded the Media sector to Attractive given increased confidence in TV centric Media names. The analyst expects distribution revenue growth to accelerate in FY17 as the industry exits a period of major mergers among pay-TV distributors that resulted in significant reductions in distribution fees, incremental contribution from new streaming entrants, and the launch of OTT services. Swinburne said TV advertising is proving "resilient" and valuation levels are defendable as earnings are poised to accelrate, with US tax reform an additional tailwind. He recommends his new "Final Four" of Disney (DIS) and Madison Square Garden (MSG), which were upgraded to Overweight from Equal Weight, Viacom (VIAB), which was resumed with an Overweight, and Overweight rated Lionsgate (LGF.B).
01/27/17
OTRG
01/27/17
DOWNGRADE
OTRG
Negative
Pandora downgraded to Negative from Mixed at OTR Global
02/10/17
ADAM
02/10/17
NO CHANGE
Target $18
ADAM
Buy
Pandora likely to create more value as independent company, says Canaccord
Canaccord analyst Michael Graham said Pandora's Q4 results were solid and inline with its preannouncement. He said his thesis remains intact as he continues to see strength in subscriber conversion, which argues well for the company to remain independent in the near-term, which he believes will create the most value for shareholders. Graham reiterated his Buy rating and $18 price target on Pandora shares.
UPS UPS
$106.51

-0.61 (-0.57%)

03/13/17
WELS
03/13/17
INITIATION
WELS
Market Perform
UPS initiated with a Market Perform at Wells Fargo
03/14/17
WELS
03/14/17
INITIATION
WELS
Market Perform
UPS initiated at Wells Fargo
As noted last night, Wells Fargo started coverage of UPS with a Market Perform rating. Wells says the company's scale gives it "a formidable competitive moat." However, the firm thinks that the company may not be able to significantly boost its results, while the shift towards business to consumer e-commerce will be a "challenge" to its margins and returns, "at least in the intermediate term." Target $110-$115.
02/22/17
02/22/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. UPS (UPS) downgraded to Neutral from Buy at BofA/Merrill with analyst Ken Hoexter citing a more muted growth outlook combined with higher capex targets. 2. Ralph Lauren (RL) downgraded to Underweight from Neutral at Atlantic Equities. 3. Charter (CHTR) downgraded to Neutral from Buy at MoffettNathanson with analyst Craig Moffett citing valuation. 4. trivago (TRVG) was downgraded to Market Perform from Outperform at Cowen, while TripAdvisor (TRIP) was downgraded to Underperform from Market Perform. 5. First Solar (FSLR) downgraded to Underperform from Neutral at Credit Suisse. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/22/17
BOFA
02/22/17
DOWNGRADE
Target $114
BOFA
Neutral
UPS downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Ken Hoexter downgraded UPS to Neutral and lowered its price target to $114 from $123 citing a more muted growth outlook combined with higher capex targets. UPS management lowered its long-term growth target to approximately 6% earnings CAGR at the mid-point til 2019 and capital expenditures increased to 6-7% of 2018-19 revenue, versus approximately 4% in 2014 and 2015, the analyst wrote.
V Visa
$88.06

-1.12 (-1.26%)

02/03/17
FBCO
02/03/17
NO CHANGE
Target $100
FBCO
Outperform
Visa price target raised to $100 from $93 at Credit Suisse
Credit Suisse analyst Moshe Orenbuch raised his price target for Visa to $100 from $93 after Q1 beat on lower incentives and expenses. The analyst reiterates an Outperform rating on the shares.
02/14/17
LOOP
02/14/17
INITIATION
Target $98
LOOP
Buy
Visa initiated with a Buy at Loop Capital
Loop Capital analyst Joseph Vafi started Visa with a Buy rating and $98 price target.
01/20/17
01/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CF Industries (CF) upgraded to Buy from Underperform at BofA/Merrill with the firm's analyst upgrading the stock two notches to Buy from Underperform and increased its price target to $40 from $21. The firm's analyst said capacity rationalization is underway and said the nitrogen debate has shifted from the timing of the trough to the magnitude of the recovery. 2. Visa (V) and MasterCard (MA) were upgraded to Outperform from Neutral at Wedbush. 3. Noble Corp. (NE) upgraded to Neutral from Underperform at BofA/Merrill with the firm's analyst citing the updated fleet status report, highlighting five-year contract extensions on two jackups with Saudi Aramco. The analyst said the extensions were expected but said the strong rate is a positive sign for the overall jackup market. 4. Aaron's (AAN) upgraded to Buy from Hold at SunTrust with analyst David Magee citing yesterday's 10% selloff in shares. The analyst acknowledges the challenges in the sector but believes Aaron's Progressive division has been gaining market share at a faster rate in the virtual space which contributed to Rent-A-Center's (RCII) woes and said the two companies have a relatively low correlation. 5. Domino's Pizza (DPZ) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull citing his firm's proprietary survey, which indicated that dining consumers are seeking convenience through digital ordering and delivery and affordable value. Domino's is at the intersection of these three "powerful" trends, O'Cull tells investors in a research note. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/17
02/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kraft Heinz (KHC) and ConAgra Brands (CAG) were initiated with Buy ratings at Deutsche Bank. The firm also initiated Campbell Soup (CPB), J.M. Smucker (SJM) General Mills (GIS), Hershey (HSY), Kellogg (K) and Mondelez (MDLZ) with a Hold, as well as Pinnacle Foods (PF), Hostess Brands (TWNK) and Snyder's Lance (LNCE) with a Buy. 2. MasterCard (MA) and Visa (V) initiated with Buy ratings at Loop Capital by analyst Joseph Vafi. 3. Bioverativ (BIVV) initiated with an Outperform rating and $56 price target at Leerink by analyst Jason Gerberry. 4. Encana (ECA) initiated with an Overweight at JPMorgan. The firm also reinstated Cheniere Energy (LNG) and Cheniere Energy Partners LP (CQH) with Overweight ratings. 5. Blueprint Medicines (BPMC) initiated with an Overweight at Morgan Stanley by analyst Andrew Berens. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
TWTR Twitter
$14.54

-0.55 (-3.64%)

02/15/17
02/15/17
NO CHANGE

Odeon sees Twitter CEO stock buy bump as opportunity to short
Odeon's Jahanara Nissar would view any strength in Twitter shares after CEO Jack Dorsey publicized his purchase of shares as an opportunity to short the stock. Nissar said the stock purchase probably means a takeover is unlikely near-term, as Dorsey couldn't buy if Twitter was engaged in talks, adding the he bought a "very small" position relative to his overall holdings.
02/28/17
AGIS
02/28/17
INITIATION
Target $22
AGIS
Snap Inc. initiated with a $22 price target at Aegis
Aegis analyst Victor Anthony initiated coverage on Snap Inc. (SNAP) pre-IPO with a year-end $22 price target. Anthony is concerned about Snap's slow user growth and no growth in some regions, comparing it to Twitter's (TWTR) issues, the ease of which Facebook (FB) has replicated parts of Snap's products, Snap's lack of an ecosystem, inferior ad capabilities, an ad mix heavily weighted towards brand versus direct response, advertisers view Snap as experimental spend, lack of a defined path towards profitability, and zero investor control over corporate governance. However, the analyst's checks within the ad industry indicate marketers are "enthusiastic" about creating ads to get in front of Snap's demographic,its most valuable asset. Anthony believes Snap will be a sustained ad share gainer over the next two years, which should be enough to drive upside to the offering price range.
03/08/17
WBLR
03/08/17
NO CHANGE
WBLR
Social advertising exec sees Facebook spending rising, says William Blair
After meeting with two separate executives who head social media spending and video at a "large, digital-only agency," William Blair analyst Ralph Schackart said he came away with the impression that social and Facebook (FB) will grow again in 2017, noting that the head of social expects her clients' Facebook spending to grow around 35% this year and for their Twitter (TWTR) budgets to decline 20%-30%, with some of that due to a spending shift to Facebook. The analyst, who thinks Facebook shares have near-term upside potential to $160-$165 and still believes it can be a "$200-plus stock," keeps an Outperform rating on the name.
03/02/17
AGIS
03/02/17
INITIATION
Target $22
AGIS
Hold
Snap initiated with a Hold at Aegis
Aegis analyst Victor Anthony started Snap (SNAP) shares with a Hold rating and $22 price target. On its first day of trading, the stock is 51%, or $8.73, to $25.73. The analyst lists slow user growth and no growth in some regions as one of this concerns. He points out Twitter (TWTR) has the same issue. Anthony is also concerned by Facebook's (FB) "ease" in replicating parts of Snapchat's product across its ecosystem.
BBY Best Buy
$44.06

-1.49 (-3.27%)

03/01/17
LOOP
03/01/17
NO CHANGE
LOOP
Buy
Best Buy has history of 'underpromising and overdelivering,' says Loop Capital
Loop Capital analyst Anthony Chukumba, commenting on Best Buy's below-consensus Q1 earnings guidance, said the company has a long track record of "underpromising and overdelivering." While awaiting more details on this morning's earnings call, he said he was encouraged by the company's Q4 bottom line beat, particularly against the weak holiday quarter results reported by other retailers. Chukumba has a Buy rating on Best Buy shares.
03/02/17
LOOP
03/02/17
NO CHANGE
Target $58
LOOP
Buy
Best Buy to be major beneficiary of hhgregg closings, says Loop Capital
Loop Capital analyst Anthony Chukumba noted the announcement from hhgregg (HGGG) that it plans to close 88 stores and exit several markets. Following a location-by-location analysis, he found that over 90% of hhgregg's 220 stores have a Best Buy (BBY) within five miles or less and he expects Best Buy to be a "major beneficiary" of the closings. Chukumba reiterates his Buy rating and $58 price target on Best Buy shares.
03/03/17
BERN
03/03/17
NO CHANGE
BERN
Best Buy unlikely to get major boost from hhgregg closures, says Bernstein
Bernstein analyst Brandon Feltcher estimates that hhgregg's (HGGG) decision to close 30% of its shares will increase Best Buy's (BBY) earnings by less than 1%. He adds that even if hhgregg closes all of its stores, Best Buy's earnings will rise less than 2%. The analyst reports that hhgregg is expected to sell off its existing inventory through mid-April, and he thinks that its discounts will put pressure on Best Buy. The analyst keeps a $34 price target and an Underperform rating on Best Buy.
03/07/17
LOOP
03/07/17
NO CHANGE
Target $58
LOOP
Buy
Best Buy prices largely in line with Amazon, says Loop Capital
Loop Capital analyst Anthony Chukumba reported that the firm's periodic comparison study of Amazon (AMZN) prices versus Best Buy's found that Best Buy's prices remain largely in line with the e-commerce giant, which he believes should enable the company to continue to gain market share given upcoming mass store closings by hhgregg (HGGG) and RadioShack, two of its most significant brick-and-mortar competitors. Chukumba reiterates his $58 price target and a Buy rating on Best Buy shares.
GOOG Alphabet
$830.46

-17.94 (-2.11%)

03/20/17
PIVT
03/20/17
DOWNGRADE
Target $950
PIVT
Hold
Pivotal downgrades Alphabet to Neutral on brand safety concerns
Pivotal Research analyst Brian Wieser downgraded Alphabet (GOOGL) to Hold from Buy citing brand safety concerns and valuation following the recent rally in the shares. News last week that Havas, the sixth largest global media network, is pulling its spending from Google's YouTube and Google Display Network in the U.K. because Google was "unable to provide specific reassurances, policy and guarantees that their video or display content is classified either quickly enough or with the correct filters" is a big deal, Wieser tells investors in a research note. Many of the U.K.'s largest brands working with agencies are reportedly suspending their advertising on YouTube and/or other Google ad products due to similar concerns, Wieser points out. He sees the U.K. issues impacting Google's global growth and cut his price target for Alphabet shares to $950 from $970. The stock in premarket trading is down $2.58 to $869.79.
03/14/17
DADA
03/14/17
NO CHANGE
Target $51
DADA
Neutral
Tableau price target lowered to $51 from $55 at DA Davidson
DA Davidson analyst Jack Andrews said several data points in recent weeks lead him to believe that the total addressable market opportunity for Tableau (DATA) is being contested and/or eroded by more "heavyweight" enterprise software companies, including Google (GOOG), Microsoft (MSFT) and Workday (WDAY). Citing the continued rise of competition, Andrews reiterates a Neutral rating on Tableau and lowered his price target to $51 from $55.
FB Facebook
$138.51

-1.43 (-1.02%)

03/21/17
BTIG
03/21/17
UPGRADE
Target $175
BTIG
Buy
BTIG's Greenfield fixes mistake, upgrades Facebook to Buy
BTIG analyst Richard Greenfield upgraded Facebook to Buy from Neutral with a price target of $175. The social networking giant closed yesterday up 10c to $139.94. The secular trends toward mobile devices along with the accelerating shift of ad dollars "are simply too strong to ignore," Greenfield tells investors in a research note. The analyst highlights the "unexpected strength" of Instagram Stories as well as improvements to Facebook's video strategy. Greenfield says not having a Buy rating on Facebook in 2017 was a mistake that he's not going to allow to continue.
03/21/17
BTIG
03/21/17
UPGRADE
BTIG
Buy
Facebook upgraded to Buy from Neutral at BTIG
03/21/17
03/21/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at BTIG with analyst Richard Greenfield saying the secular trends toward mobile devices along with the accelerating shift of ad dollars "are simply too strong to ignore." The analyst highlights the "unexpected strength" of Instagram Stories as well as improvements to Facebook's video strategy. Greenfield says not having a Buy rating on Facebook in 2017 was a mistake that he's not going to allow to continue. 2. Freeport McMoRan (FCX) upgraded to Hold from Sell at Deutsche Bank with analyst Chris Terry citing a more positive Industrials commodity view. He raised his price target for Freeport shares to $14 from $12.50. 3. Wynn Resorts (WYNN) upgraded to Buy from Hold at Aegis with analyst David Bain saying Wynn Macau casinos posses peer-high leverage to VIP and and high-end premium mass segmentation which is leading a still early stage Macau recovery. 4. Motorola Solutions (MSI) upgraded to Buy from Hold at Jefferies with analyst George Notter saying consensus expectations are too low while risks to the LMR franchise increasingly look like a "red herring." After spending time with management, Notter upped his price target for the shares to $100 from $75. 5. Carnival (CCL) upgraded to Outperform from Market Perform at William Blair with analyst Sharon Zackfia saying the company is well positioned to exceed expectations with earnings growth likely to accelerate into fiscal 2018. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/17/17
UBSW
03/17/17
NO CHANGE
Target $165
UBSW
Buy
Facebook price target raised to $165 from $155 at UBS
UBS analyst Eric Sheridan raised his price target on Facebook to $165 from $155 citing his confidence the company can keep growing its core advertising business while shifting its emerging businesses - like Messenger, WhatsApp and Oculus - from user growth and ecosystem investments to monetization. The analyst sees better than expected growth and margins and forward multiples as attractive relative to its growth/return profile. Sheridan reiterated his Buy rating Facebook shares.
PJC Piper Jaffray
$63.35

-3.9 (-5.80%)

04/15/16
SDLR
04/15/16
DOWNGRADE
SDLR
Hold
Piper Jaffray downgraded to Hold due to valuation at Sandler O'Neill
Sandler O'Neill analyst Mike Adams downgraded Piper Jaffray to Neutral from Buy citing year-to-date outperformance and maintained his $49 price target on shares.
IBM IBM
$173.88

-1.82 (-1.04%)

02/23/17
BOFA
02/23/17
NO CHANGE
Target $200
BOFA
Buy
IBM price target raised to $200 from $185 at BofA/Merrill
02/23/17
RAJA
02/23/17
NO CHANGE
RAJA
Strong Buy
NVIDIA the 'acceleration supplier of choice' for cloud/HPC, says Raymond James
After meeting with representatives from IBM (IBM) and Kinetic, Raymond James analyst J. Steven Smigie said he came away with the impression that NVIDIA (NVDA) remains the "acceleration supplier of choice for alternative cloud/HPC solutions" versus Intel (INTC) and that adoption for GPU-accelerated enterprise and database management applications is "still in the earliest innings." He maintains a Strong Buy rating on NVIDIA, which was just downgraded to Underperform at BMO Capital and to Reduce at Nomura.
03/16/17
MSCO
03/16/17
NO CHANGE
Target $212
MSCO
Overweight
IBM target raised to $212 on 'undervalued' cloud opportunity at Morgan Stanley
Morgan Stanley analyst Katy Huberty said IBM's cloud opportunity remains underappreciated as she expects its $3B Public Cloud business to grow in line with the market at a 33% CAGR from 2016-20 with its gross and operating margins expanding to industry average by the end of that period. Huberty raised her price target on IBM shares to $212 from $187 and keeps an Overweight rating on the stock.
ANF Abercrombie & Fitch
$11.43

-0.24 (-2.06%)

01/04/17
FBRC
01/04/17
UPGRADE
Target $13
FBRC
Market Perform
FBR upgrades Abercrombie to Market Perform after selloff
FBR Capital analyst Susan Anderson upgraded Abercrombie & Fitch to Market Perform from Underperform citing the stock's 28% decline since her November 15, 2016 downgrade. Near-term negative results are likely priced into the stock, Anderson tells investors in a research note. She believes, however, that Abercrombie's same-store-sales will remain challenged driven by the A&F brand and Europe. The analyst lowered her price target for the shares to $13 from $14.
01/03/17
01/03/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Jefferies analyst Randal Konik downgraded Abercrombie & Fitch (ANF) to Hold saying the turnaround continues to struggle at the Abercrombie brand, with no visibility of a turnaround in sight. Also this morning, Oppenheimer analyst Anna Andreeva downgraded Abercrombie & Fitch to Underperform, saying consensus estimates have further downside as the brands "remain in transition amidst increasingly more competitive teen landscape." 2. Oppenheimer analyst Ittai Kidron downgraded Tableau (DATA) to Perform from Outperform to reflect the scope of near-term transition challenges integrating new leadership, the ratable shift, and competition, all hampering near-term upside potential. The analyst also cut Nokia's (NOK) rating to Perform from Outperform. 3. Piper Jaffray analyst Erinn Murphy downgraded Michael Kors (KORS) to Neutral saying the handbag category has been "highly promotional" while inventory levels have been high, particularly at department stores. The analyst sees no positive catalyst in the near-term for shares to re-rate higher and cut her price target for Kors to $48 from $60. 4. JPMorgan analyst Jimmy Bhullar downgraded Voya Financial (VOYA) to Underweight saying the risk/reward skews negative following the stock's outperformance in the second half of 2016. The analyst remains concerned about Voya's "subpar" return-on-equity. 5. JPMorgan analyst Michael Weinstein downgraded Medtronic (MDT) to Neutral saying the new macro environment of rising rates and a strengthening dollar will make it challenging for the shares to outperform in 2017. This morning Weinstein also downgraded Becton Dickinson (BDX) to Neutral saying the new macro environment of rising rates and a strengthening dollar will make it challenging for defensive growth names to outperform in 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/03/17
WOLF
03/03/17
DOWNGRADE
WOLF
Underperform
Abercrombie & Fitch downgraded to Underperform at Wolfe Research
Wolfe Research downgraded Abercrombie & Fitch to Underperform from Peer Perform with a $10 price target citing low visibility into a comp turnaround, margin contraction, and a potentially unsustainable dividend yield.
01/04/17
FBRC
01/04/17
UPGRADE
Target $13
FBRC
Market Perform
Abercrombie & Fitch upgraded to Market Perform from Underperform at FBR Capital
FBR Capital analyst Susan Anderson upgraded Abercrombie & Fitch to Market Perform with a slightly reduced price target of $13.
SSNLF Samsung

02/02/17
OPCO
02/02/17
NO CHANGE
Target $70
OPCO
Outperform
Cirrus Logic price target raised to $70 from $65 at Oppenheimer
Oppenheimer analyst Rick Schafer raised his price target for Cirrus Logic (CRUS) to $70 from $65 after the company reported Q3 results easily ahead of the Street's estimates on well-documented, better than feared Apple's (AAPL) iPhone shipments. The analyst believes the softer topline near-term reflects Samsung's (SSNLF) decision to opt for a lower-end smart codec in the GS8. Additionally, Schafer notes that the March guide, while lower than consensus, still implies 38% year over year growth. He remains a buyer and reiterates an Outperform rating on Cirrus Logic's shares.
03/03/17
03/03/17
DOWNGRADE
Target $8

Hold
Immersion downgraded to Hold at Craig-Hallum
As previously reported, Craig-Hallum analyst Anthony Stoss downgraded Immersion (IMMR) to Hold from Buy as the company's revenue and net loss guide for 2017 was worse than expectations due to continued high litigation expense from the Apple (AAPL) trial and the potential for incremental expense should Immersion sue Samsung (SSNLF), and revenue guidance was worse than expected. The analyst also lowered his price target on Immersion's shares to $8 from $11.
03/09/17
CHLM
03/09/17
NO CHANGE
CHLM
Buy
iPhone 8 may have STMicroelectronics facial recognition tech, says Craig-Hallum
Craig-Hallum notes there has been speculation that perhaps there will be component shortages preventing Apple (AAPL) from launching the iPhone 8 in late September. The speculation has surrounded finger print sensors, AMOLD panels and now 3D sensing components, the firm says, pointing out that most believe STMicroelectronics (STM) could have 2 sensors in iPhone 8. Furthermore, Craig-Hallum thinks the latter could have a new facial recognition technology in Apple's upcoming smartphone as well. The firm believes STMicroelectronics has already started to produce and stockpile parts for the Apple 8 and does not expect any issues on its side. Craig-Hallum notes that Samsung (SSNLF) officials have stated they will also put facial recognition in the upcoming Galaxy 8, which should be supplied by STMicroelectronics. The firm has a Buy rating on STMicroelectronics' shares.
03/02/17
CHLM
03/02/17
NO CHANGE
Target $260
CHLM
Buy
Broadcom price target raised to $260 from $210 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his price target for Broadcom (AVGO) to $260 from $210 after the company reported "strong results" driven by better than expected Apple's (AAPL) iPhone 7 sales coupled with expected NAND tightness driving growth in its enterprise storage business on the HDD side. The analyst notes that Enterprise business was up 26% quarter over quarter due to content gains/initial builds for Samsung's (SSNLF) Galaxy S8 helping offset the seasonal decline at Apple coupled with strong demand from cloud data center/fiber optics customers driving the wired business. Stoss remains a buyer of Broadcom heading into Apple's next generation phone as he looks for the company to benefit from both content expansion and unit growth. He reiterates a Buy rating on Broadcom's shares.
KSS Kohl's
$37.64

-0.92 (-2.39%)

03/02/17
JEFF
03/02/17
NO CHANGE
Target $19
JEFF
Hold
Jefferies 'impressed' with Under Armour placement at Kohl's
After visiting nearly a dozen Kohl's (KSS) locations in the tri-state area to view the newly-launched Under Armour (UA, UAA) brand in stores, Jefferies analyst Randal Konik says he's "impressed" with Under Armour's placement and opportunity. Under Armour represents the largest brand launch in history for Kohl's, Konik tells investors in a research note. While the brand debuted at full-price versus Nike (NKE) and Adidas (ADDYY) at buy-one-get-one 50% off, Kohl's will likely incorporate Under Armour into its promotional architecture by Fall 2017, the analyst contends. He keeps a Hold rating on Under Armour with a $19 price target.
03/21/17
CLVD
03/21/17
NO CHANGE
CLVD
Kohl's Q1 comps trending below consensus, says Cleveland Research
03/08/17
SUSQ
03/08/17
NO CHANGE
Target $14
SUSQ
Negative
Under Armour 10-K elevates concerns, says Susquehanna
Susquehanna analyst Sam Poser said his review of Under Armour's (UAA) 10-K has elevated his concern as the risks section included new language that business could be impacted if negative publicity diminishes the appeal of its brand. He believes the CEO's comments following its results will hurt the ability of the company to attract fashion influencers, which is one of the things upon which the analyst's negative thesis is predicated. Poser maintained his Negative rating and $14 price target on Under Armour shares.
02/17/17
02/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Square (SQ) initiated with a Buy at Citi by analyst Peter Christiansen, who said the company has the capability of "redefining" brick-and-mortar payments and commerce enablement. 2. Aerie Pharmaceuticals (AERI) initiated by Roth Capital analyst Sa'ar Yaniv with a Buy rating and $69 price target as he expects Rhopressa and Roclatan approval in 2018 and 2019. 3. Aegis analyst Chris Kapsch initiated Albemarle (ALB) with a Buy and a $108 price target, calling it a "must-own" stock over at least the next couple years. 4. Arch Coal (ARCH) initiated with a Buy at Jefferies by analyst Christopher LaFemina, citing the company's portfolio of "low-cost" U.S. coal assets and a "clean" balance sheet. 5. Piper Jaffray analyst Erinn Murphy assumed coverage of Nordstrom (JWN) with a Neutral rating and $41 price target, saying she believes price transparency may continue to hinder the company's results. Murphy also assumed coverage of J.C. Penney (JCP) with a Neutral rating and $8 price target, noting worries about the underlying secular pressure Amazon.com (AMZN) is putting on the industry, and assumed coverage of Kohl's (KSS) with a Neutral rating and $40 price target, as she believes earnings growth will be tough amid the current environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
UA Under Armour
$17.52

-0.74 (-4.05%)

02/27/17
02/27/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Tesla (TSLA) downgraded to Sell from Neutral at Goldman by analyst David Tamberrino, who also lowered his price target for the shares to $185 from $190. The analyst has concerns over the execution of the Model 3 launch, the company's "unproven" solar business as well as its near-term cash needs. 2. Under Armour (UAA) downgraded to Reduce from Neutral at Nomura by analyst Simeon Siegel, who cut his price target to $16 from $27, saying the company's Q4 report affirmed many of his concerns. Siegel is concerned Under Armour has matured past its high growth phase, and even in an overly optimistic scenario, believes shares are fairly valued at best and anything short of perfection could pressure shares as slowing growth rates normalize the lofty multiple. 3. Urban Outfitters (URBN) downgraded to Sell at MKM Partners by analyst Roxanne Meyer, who expects sales and margins to deteriorate meaningfully in 2017 at Anthropologie, and sees risk at the flagship brand as it laps reductions in markdowns and as key brands widen distribution. 4. Lumentum (LITE) downgraded to Neutral from Buy at MKM Partners by analyst Michael Genovese, who said demand conditions in China are not as strong as last year and there are technology transitions in Chinese Optical. He believes Lumentum will lose share in Chinese line-side and client-side transmission and believes shares reflect a lot of potential good 3D sensing news. 5. J.C. Penney (JCP) downgraded to Neutral from Buy at B. Riley by analyst Jeff Van Sinderen, who cut his price target for the shares to $7.50 from $12 following the company's Q4 results. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/15/17
02/15/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Fossil (FOSL) downgraded to Underperform from Market Perform at Wells Fargo, with analyst Ike Boruchow saying Q4 sales missed expectations "despite a much hyped push into wearables" while Q1 trends suggest that reorder activity has been "extremely weak following their holiday sell-in." 2. Under Armour (UA) downgraded to Negative from Neutral at Susquehanna, with analyst Sam Posner arguing that 20% annual revenue growth is "a thing of the past for the foreseeable future." Poser tells investors that commentary by CEO Kevin Plank in the current "polarized political climate" make it "nearly impossible" to effectively build a cool urban lifestyle brand, noting that several stars reacted unfavorably to his comments. 3. Hologic (HOLX) downgraded to Neutral from Buy at BofA/Merrill, with analyst Derik de Bruin saying the Cynosure (CYNO) acquisition enhances growth but at lower margins. The analyst said Cynosure adds new higher growth revenue but margins and cash flows are low relative to Hologic's and will not fully offset dilution from the recent blood screening divestiture. 4. Aircastle (AYR) downgraded to Market Perform from Outperform at Cowen by analyst Helane Becker, who said the company's growth rate is slowing as aircraft acquisition is more competitive. Aircastle was also downgraded at FBR Capital to Market Perform from Outperform. 5. Convergys (CVG) downgraded to Hold from Buy at SunTrust by analyst Frank Atkins, who said top line growth may be limited near-term due to increased uncertainty driving weakness in the demand environment. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
PEP PepsiCo
$111.77

0.62 (0.56%)

03/21/17
JPMS
03/21/17
INITIATION
Target $125
JPMS
Overweight
PepsiCo initiated with an Overweight at JPMorgan
JPMorgan analyst Andrea Teixeira started PepsiCo with an Overweight rating and $125 price target.
03/02/17
BERN
03/02/17
NO CHANGE
BERN
PepsiCo could be targeted by Kraft Heinz, says Bernstein
Bernstein analyst Ali Dibadj says that Kraft Heinz,(KHC) could look to buy PepsiCo (PEP). The analyst says that the deal would be 30% accretive to Kraft Heinz's EPS. The analyst thinks that PepsiCo's CEO could support the deal, especially ,since the company's cost cutting could start to slow.
02/22/17
RBCM
02/22/17
NO CHANGE
RBCM
PepsiCo a more likely target of Kraft Heinz than Coca-Cola, says RBC Capital
RBC Capital analyst Nik Modi says that PepsiCo (PEP) is a more likely takeover target for Kraft Heinz (KHC) and 3G than Coca-Cola (KO). The latter company's refranchising initiative creates a "poison pill" because it limits the ability of acquirers to control the company's costs, according to Modi. Additionally, 3G could easily spin off Pepsi Beverages and potentially look to merge it with Kraft Heinz, Modi believes.
01/09/17
LEHM
01/09/17
INITIATION
Target $102
LEHM
Equal Weight
PepsiCo initiated with an Equal Weight at Barclays
Barclays analyst Lauren Lieberman started PepsiCo with an Equal Weight rating and $102 price target.
GPS Gap
$22.82

-0.64 (-2.73%)

03/08/17
GUGG
03/08/17
INITIATION
GUGG
Neutral
Gap initiated with a Neutral at Guggenheim
01/06/17
BARD
01/06/17
NO CHANGE
Target $26
BARD
Neutral
Gap estimates raised but risk/reward remains balanced, says Baird
Baird analyst Mark Altschwager noted Gap reported better than expected comps buoyed by Old Navy and the company signaled modest upside to guidance. The analyst raised his estimates but said visibility into sustainable sales/margin improvement remains cloudy, yielding a balanced risk/reward at current levels. Altschwager maintained his Neutral rating and $26 price target on Gap shares.
02/07/17
JEFF
02/07/17
NO CHANGE
Target $36
JEFF
Buy
Jefferies calls on Gap to consider alternatives for Banana
While the Gap brand last night reported its second consecutive month of positive comparable sales, and Old Navy remained positive, Banana Republic continued to struggle with comp sales down 4%, Jefferies analyst Randal Konik tells investors in a research note. Management needs to take action, the analyst argues. He believes management should consider strategic alternatives for Banana including a potential sale, massively reducing the store footprint, or shutting down the brand. Konik has a Buy rating on Gap with a $36 price target.
12/19/16
12/19/16
NO CHANGE

Wells Fargo identifies retailers most at risk from Trump policies
Wells Fargo says that apparel retailers, footwear makers, and watch makers import large amounts and have low gross margins. As a result, the firm believes that such companies face the most risk from upcoming federal policy changes, and it is more cautious on Carter's (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil (FOSL), and Gap (GPS).
AXP American Express
$77.53

-1.32 (-1.67%)

03/09/17
SUSQ
03/09/17
NO CHANGE
Target $91
SUSQ
Positive
American Express price target raised to $91 from $83 at Susquehanna
Susquehanna analyst James Friedman raised his price target on American Express to $91 from $83 as he believes the company is returning to 10% earnings growth. The analyst cited a modest improvement in its billed business, stabilized cost structure, and expanded merchant acceptance. Friedman reiterated his Positive rating on American Express shares.
01/30/17
01/30/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) and Madison Square Garden (MSG) were upgraded to Overweight from Equal Weight at Morgan Stanley. 2. Dick's Sporting (DKS) upgraded to Buy from Neutral at Goldman with analyst Stephen Tanal saying he believes Dick's is well positioned in a post The Sports Authority world and will reap the rewards of consolidation through sales and earnings growth driven by share gains and improved product allocations from key vendors. Further, Dick's is transitioning to a fully in-sourced eCommerce operation, which should drive improved profitability. 3. American Express (AXP) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Sanjay Sakhrani citing improved fundamentals and visibility. "The low end of the company's 2017 earnings guidance is 'very achievable' just through stated operating cost reductions and capital management, and any revenue growth represents upside potential," Sakhrani tells investors in a research note. He raised his price target for American Express shares to $91 from $81. 4. Royal Caribbean (RCL) upgraded to Buy from Hold at Argus with analyst John Staszak says the company has "few competitors and strong market opportunities." He expects it to benefit from lower costs and increased international demand going forward. 5. Movado (MOV) upgraded to Buy from Neutral at Sidoti with analyst Frank Camma saying recent retail weakness is reflected in price and tariff concerns are overblown. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/06/17
OPCO
03/06/17
NO CHANGE
Target $97
OPCO
Outperform
Oppenheimer recommends American Express ahead of investor day
Oppenheimer analyst Ben Chittenden continues to recommend shares of American Express ahead of its Investor Day on March 8. The analyst thinks that most of the headwinds are embedded in the valuation at current levels, and the cyclical benefit to billed business from a potential turn in T&E is not. He reiterates an Outperform rating and $97 price target on the shares.
03/03/17
BOFA
03/03/17
NO CHANGE
Target $94
BOFA
Buy
American Express price target raised to $94 from $90 at BofA/Merrill

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.